Page last updated: 2024-11-01

orphenadrine and Hearing Loss, Sensorineural

orphenadrine has been researched along with Hearing Loss, Sensorineural in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.

Research Excerpts

ExcerptRelevanceReference
"Tinnitus produced by middle-ear myoclonus is a rare condition."1.32Objective high-frequency tinnitus of middle-ear myoclonus. ( Abdul-Baqi, KJ, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdul-Baqi, KJ1

Other Studies

1 other study available for orphenadrine and Hearing Loss, Sensorineural

ArticleYear
Objective high-frequency tinnitus of middle-ear myoclonus.
    The Journal of laryngology and otology, 2004, Volume: 118, Issue:3

    Topics: Audiometry, Pure-Tone; Ear Diseases; Ear, Middle; Hearing Loss, Bilateral; Hearing Loss, Sensorineur

2004